Exploring the Association between Diabetes Mellitus, Obesity, and Recurrent Stroke Events: a Cross-sectional Study

Marlina Marlina, Maulida Sari, Rahmalia Amni

Abstract


Stroke is the most significant cause of death and cause of disability in the world because it causes neurological deficits in sufferers, such as muscle paralysis, swallowing weakness, communication damage, and vision disorders to cause death. Stroke can be recurrent and have a severe impact compared to the initial attack. The purpose of this study was to explore the association between diabetes mellitus, obesity, and the incidence of recurrent strokes in post-stroke patients at a regional general hospital in Aceh province. It is a cross-sectional study carried out from 3–12 August 2022. The sampling technique used in this study was a purposive sampling of 154 patients. The instruments used were questionnaires of patient demographic characteristics, data analysis using chi-square assays, and logistic regression. The results showed that there was no association between diabetes mellitus (p>0.05) and obesity (p>0.05) with the incidence of recurrent strokes. One of the preventive measures for the occurrence of recurrent strokes is to provide education about the prevention of recurrent strokes related to diabetes mellitus and obesity, one of which is a healthy lifestyle. In conclusion, there is no relationship between diabetes mellitus, obesity, and the incidence of recurrent strokes in post-stroke patients at a regional general hospital in Aceh province.

Keywords


Diabetes mellitus; obesity; recurrent strokes

Full Text:

PDF

References


Kuriakose D, Xiao Z. Pathophysiology and treatment of stroke: present status and future perspectives. Int J Mol Sci. 2020;21(20):7609.

Saver JL, Hankey GJ. Stroke prevention and treatment: an evidance-based approach. 2nd edition. Cambridge: Cambridge University Press; 2021.

Tadi P, Lui F. Acute stroke. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan [cited 2024 June 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535369.

Lindsay MP, Norrving B, Sacco RL, Brainin M, Hacke W, Martins S, et al. World Stroke Organization (WSO): global stroke fact sheet 2019. Int J Stroke. 2019;14(8):806–17.

Katan M, Luft A. Global burden of stroke. Semin Neurol. 2018;38(2):208–11.

Wafa HA, Wolfe CDA, Emmett E, Roth GA, Johnson CO, Wang Y. Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years. Stroke. 2020;51(8):2418–27.

Feigin VL, Brainin M, Norrving B, Martins S, Sacco RL, Hacke W, et al. World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17(1):18–29.

Corrigendum to: World Stroke Organization (WSO): global stroke fact sheet 2022. Int J Stroke. 2022;17(4):478.

eClinicalMedicine. The rising global burden of stroke. EClinicalMedicine. 2023;59:102028.

Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia. Laporan nasional Riskesdas 2018. Jakarta: Badan Penelitian dan Pengembangan Kesehatan; 2019.

Zhuo Y, Wu J, Qu Y, Yu H, Huang X, Zee B, et al. Clinical risk factors associated with recurrence of ischemic stroke within two years: a cohort study. Medicine (Baltimore). 2020;99(26):e20830.

Khanevski AN, Bjerkreim AT, Novotny V, Naess H, Thomassen L, Logallo N, et al. Recurrent ischemic stroke: Incidence, predictors, and impact on mortality. Acta Neurol Scand. 2019;140(1):3–8.

American Stroke Association. Stroke risk factors [Internet]. Dallas: American Stroke Association; 2023 [cited 2024 May 15]. Available from: https://www.stroke.org/en/about-stroke/stroke-risk-factors.

Shiozawa M, Kaneko H, Itoh H, Morita K, Okada A, Matsuoka S, et al. Association of body mass index with ischemic and hemorrhagic stroke. Nutrients. 2021;13(7):2343.

Quiñones-Ossa GA, Lobo C, Garcia-Ballestas E, Florez WA, Moscote-Salazar LR, Agrawal A. Obesity and stroke: does the paradox apply for stroke? Neurointervention. 2021;16(1):9–19.

Choudhury MSJH, Chowdhury MTI, Nayeem A, Jahan WA. Modifiable and non-modifiable risk factors of stroke: a review update. J Natl Inst Neurosci Bangladesh. 2015:1(1):22–6.

Johansson A, Drake I, Engström G, Acosta S. Modifiable and non-modifiable risk factors for atherothrombotic ischemic stroke among subjects in the Malmö Diet and Cancer study. Nutrients. 2021;13(6):1952.

Firuza KN, Khamsiyati SI, Lahdji A, Yekti M. Analisis faktor risiko serangan stroke berulang pada pasien usia produktif. Med Art. 2022;4(1):1–10.

Mihejeva I, Vētra A, Bērziņa G. Factors associated with long-term mortality for stroke unit patients in Latvia. Brain Behav. 2018;8(12):e01152.

Ma YH, Leng XY, Dong Y, Xu W, Cao XP, Ji X, et al. Risk factors for intracranial atherosclerosis: a systematic review and meta-analysis. Atherosclerosis. 2019;281:71–7.

Zhang L, Li X, Wolfe CDA, O'Connell MDL, Wang Y. Diabetes as an independent risk factor for stroke recurrence in ischemic stroke patients: an updated meta-analysis. Neuroepidemiology. 2021;55(6):427–35.

Magliano DJ, Boyko EJ; IDF Diabetes Atlas 10th edition scientific committee. IDF diabetes atlas. 10th edition. Brussels: International Diabetes Federation; 2021.

World Health Organization. World health statistics 2021 monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2021.

Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288–98.

Kariasa IM, Nurachmah E, Setyowati, Koestoer RA. Analysis of participants’ characteristics and risk factors for stroke recurrence. Enferm Clin. 2019;29(Suppl 2):286–90.

Kumral E, Erdoğan CE, Arı A, Bayam FE, Saruhan G. Association of obesity with recurrent stroke and cardiovascular events. Neurol (Paris). 2021;177(4):414–21.




DOI: https://doi.org/10.29313/gmhc.v12i2.13555

pISSN 2301-9123 | eISSN 2460-5441


Visitor since 19 October 2016: 


Free counters!


Global Medical and Health Communication is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.